19.04.2022 12:20:00

Johnson & Johnson Announces Dividend Increase of 6.6%

NEW BRUNSWICK, N.J., April 19, 2022 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a 6.6% increase in the quarterly dividend, from $1.06 per share to $1.13 per share.

"In recognition of our 2021 results, strong financial position, and confidence in the future of Johnson & Johnson, the Board of Directors has voted to increase the quarterly dividend for the 60th consecutive year," said Joaquin Duato, Chief Executive Officer of the company.

At the new rate, the indicated dividend on an annual basis is $4.52 per share compared to the previous rate of $4.24 per share. The next quarterly dividend is payable on June 7, 2022 to shareholders of record as of the close of business on May 24, 2022. The ex-dividend date is May 23, 2022.

About Johnson & Johnson
At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That's why for more than 130 years, we have aimed to keep people well at every age and every stage of life. Today, as the world's largest and most broadly-based health care company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. We are blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity.                              

(PRNewsfoto/Johnson & Johnson)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/johnson--johnson-announces-dividend-increase-of-6-6-301527648.html

SOURCE Johnson & Johnson

Analysen zu Johnson & Johnsonmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Johnson & Johnson 139,46 0,46% Johnson & Johnson